Cancer survival News
The study, published in the Journal of Clinical Oncology, followed 826 participants in a clinical trial for a median of 6.5 years after they were treated with surgery and chemotherapy.
The aim of neoadjuvant chemotherapy is to eliminate active cancer cells – producing a complete response – before surgery.
Patients with breast, gastric or lung cancers survived longer when they had higher levels of Bmal1 protein.
The device, called Optune, is made by Novocure, based in Jersey, an island near England.
Encouraging women to invest in their health, actress Lisa Ray, who won a battle against cancer, says women should take care of their finances to face tough situations, including cancer treatment.
Loading...